Sartorius Stedim Biotech SA (STU:56S1)
€ 193.8 -3.9 (-1.97%) Market Cap: 18.88 Bil Enterprise Value: 22.44 Bil PE Ratio: 57.41 PB Ratio: 6.74 GF Score: 95/100

Q1 2021 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript

Apr 21, 2021 / 01:30PM GMT
Release Date Price: €384.7 (+0.60%)
Operator

Good day, and warm welcome to the Sartorius and Sartorius Stedim Biotech Conference call on the Q1 2021 Results. Today's conference is being recorded.

At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead.

Joachim Kreuzburg
Sartorius Stedim Biotech S.A. - Chairman & CEO

Thank you very much. Welcome, everybody, and good day. I welcome you to our today's conference call on our Q1 results for Sartorius and Sartorius Stedim Biotech Group as well. As always, I'm running this call together with our CFO, Rainer Lehmann, who will present on all the details of the numbers for Sartorius. I will just kick it off by commenting the most important highlights for Q1 of this year.

First of all, both divisions have achieved a 60-plus percent top line growth. And at the same time, a very substantial margin expansion. We will comment on that in much more detail in a minute. We have achieved strong organic growth. This should not be forgotten in light of the significant impact from our corona-related

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot